An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Endometrial Cancer
-
Age: Between 18 Year(s) - 100 Year(s)
-
Gender: Female
-
Other Inclusion Criteria:
1) Histologically confirmed diagnosis of advanced or metastatic endometrial cancer with disease progression on or after treatment with at least 1 platinum-containing regimen for advanced or metastatic disease. 2) Willing to provide tumor tissue sample (fresh or archived).
You may not be eligible for this study if the following are true:
-
1) Histologically confirmed diagnosis of sarcoma of the uterus. 2) Has disease eligible for potentially curative treatment with standard chemotherapy, surgical resection, or chemoradiotherapy. 3) Receipt of anticancer therapy within 28 days of the first administration of study treatment, with the exception of localized radiotherapy.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.